Rebecca Jones
About Rebecca Jones
Rebecca Jones is the Director of Grants, Medical Operations & Alliances at Alkermes in Greater Boston, with extensive experience in medical communications and operations from previous roles at Sage Therapeutics and Vertex Pharmaceuticals.
Current Position at Alkermes
Rebecca Jones is currently the Director of Grants, Medical Operations & Alliances at Alkermes. She operates within the Greater Boston area, where she oversees grant-related activities and spearheads medical operations and alliances for the company. This role builds on her extensive experience in medical affairs and operations.
Previous Role at Sage Therapeutics
Rebecca Jones worked at Sage Therapeutics, where she held multiple leadership roles. From 2021 to 2022, she served as the Director of Medical Affairs Strategic Operations in Cambridge, Massachusetts. Before that, she was the Director of Operations for HEOR & Value Demonstration for five months, illustrating her versatility in strategic and operational facets of medical affairs.
Experience at Vertex Pharmaceuticals
Rebecca Jones accumulated extensive experience during her tenure at Vertex Pharmaceuticals. She progressed from a Grants Manager to the Associate Director of Grants & ISS - Global Medical Communications and Operations from 2015 to 2019, demonstrating her growing expertise in grant management and medical communications over four years in Boston.
Roles at GENZYME CORPORATION
Rebecca Jones' early career at GENZYME CORPORATION involved several key roles in Cambridge. She started as a Clinical Contracts Coordinator in Biomedical and Regulatory Affairs in 2007. She later became a Medical Affairs Associate in the Solid Organ Transplant Business Unit, before transitioning to a Marketing Communications Specialist role within the same business unit, showcasing her ability to switch between medical affairs and marketing communications.
Educational Background
Rebecca Jones holds a Bachelor of Arts in Art History and Italian from Syracuse University, where she studied between 2000 and 2004. Her academic background in the arts has given her a distinctive perspective, which she later channeled into her diverse professional roles in medical and regulatory affairs.